| Period Ending | Dec 30, 2012 | Dec 30, 2011 | Dec 30, 2010 |
|---|
|
Total Revenue
|
273,241
|
268,449
|
258,868
| | Cost of Revenue | 48,910 | 49,116 | 38,999 | | |
Gross Profit
|
224,331
|
219,333
|
219,869
| |
|
Operating Expenses |
|
Research Development | 23,453 | 24,218 | 23,437 |
|
Selling General and Administrative | 206,908 | 223,522 | 183,535 |
|
Non Recurring |
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | | |
Operating Income or Loss
|
(6,030)
|
(28,407)
|
12,897
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 190 | 444 | 42 |
|
Earnings Before Interest And Taxes | (5,840) | (27,963) | 12,939 |
|
Interest Expense |
-
| 5 | 66 |
|
Income Before Tax | (5,840) | (27,968) | 12,873 |
|
Income Tax Expense | 29,991 | (7,980) | (411) |
|
Minority Interest |
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (35,831) | (19,988) | 13,284 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | | |
Net Income
|
(35,831)
|
(19,988)
|
13,284
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(35,831)
|
(19,988)
|
13,284
|
|